Lodz, Poland

Joanna Brzezinska

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Joanna Brzezinska: Innovator in Therapeutic Applications

Introduction

Joanna Brzezinska is a prominent inventor based in Lodz, Poland. She has made significant contributions to the field of therapeutic applications, particularly in the development of arginase inhibitors. With a total of 3 patents to her name, her work is paving the way for new treatments in medicine.

Latest Patents

One of her latest patents is focused on arginase inhibitors and their therapeutic applications. This patent discloses small molecule therapeutic compounds that are potent inhibitors of arginase 1 and arginase 2 activity. It also includes pharmaceutical compositions comprising these compounds, along with methods for using them to treat or prevent diseases associated with arginase activity. Another notable patent involves dipeptide piperidine derivatives, which relates to pharmaceutical compositions and methods for preparing and using these compositions for similar therapeutic purposes.

Career Highlights

Joanna Brzezinska is currently associated with Oncoarendi Therapeutics S.A., where she continues to innovate in the field of pharmaceuticals. Her work is characterized by a strong focus on developing effective treatments for conditions linked to arginase activity.

Collaborations

Throughout her career, Joanna has collaborated with notable colleagues, including Roman Blaszczyk and Adam A. Golebiowski. These collaborations have further enhanced her research and development efforts in therapeutic applications.

Conclusion

Joanna Brzezinska is a trailblazer in the field of therapeutic innovations, with her patents contributing significantly to medical science. Her ongoing work at Oncoarendi Therapeutics S.A. continues to inspire advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…